IVERIC bio, Inc. (ISEE): Price and Financial Metrics


IVERIC bio, Inc. (ISEE)

Today's Latest Price: $5.39 USD

0.19 (-3.41%)

Updated Jan 21 10:43am

Add ISEE to Watchlist
Sign Up

Overall POWR Rating

Sign Up to See Ratings...FREE!

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 484 in Biotech

See all "A" rated Strong Buy stocks

ISEE Stock Price Chart Interactive Chart >

Price chart for ISEE

ISEE Price/Volume Stats

Current price $5.39 52-week high $7.98
Prev. close $5.58 52-week low $2.64
Day low $5.33 Volume 147,017
Day high $5.66 Avg. volume 631,418
50-day MA $6.52 Dividend yield N/A
200-day MA $5.22 Market Cap 482.77M

IVERIC bio, Inc. (ISEE) Company Bio

IVERIC bio, Inc. (formerly Ophthotech Corporation) is a biopharmaceutical company specializing in the development of novel therapeutics to treat back of the eye diseases, with a focus on developing innovative therapies for age-related macular degeneration (AMD). The company was founded in 2007 and is based in New York, New York.

Most Popular Stories View All

• How to Outperform the Stock Market in 2021

• Is Shopify a Smart Buy for 2021?

• 3 Auto Stocks to Buy Instead of Tesla: Ford, GM, and Tata Motors

• Better Buy: Marathon Patent Group vs. Canaan

• 3 Lesser-Known Biotech Stocks that are Surging

View All Top Stories

ISEE Latest News Stream

Event/Time News Detail
Loading, please wait...
View All ISEE News

ISEE Latest Social Stream

Loading social stream, please wait...

View Full ISEE Social Stream

Latest ISEE News From Around the Web

Below are the latest news stories about IVERIC bio Inc that investors may wish to consider to help them evaluate ISEE as an investment opportunity.

4 Health Stocks Stonepine Capital Loves (1 Has Gained 233% Since September 29)

Timothy P. Lynch’s Stonepine Capital is a life science-focused hedge fund that seeks to utilize its industry experience to uncover undervalued and under-the-radar health companies. The fund takes a long-term approach to its small number of investments, which are focused on companies that have successfully commercialized products and which are in a strong financial position. […]

Yahoo | October 27, 2020

IVERIC bio to Report Third Quarter 2020 Financial Results and Host Conference Call on Monday, November 2, 2020

IVERIC bio today announced that it will report its third quarter 2020 financial and operating results on Monday, November 2, 2020.

Yahoo | October 26, 2020

IVERIC bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

IVERIC bio reported that it granted a newly hired employee a non-statutory stock option to purchase 14,000 shares of the Company’s common stock.

Yahoo | October 2, 2020

IVERIC bio, Inc. (ISEE): Hedge Funds Are Snapping Up

How do you pick the next stock to invest in? One way would be to spend days of research browsing through thousands of publicly traded companies. However, an easier way is to look at the stocks that smart money investors are collectively bullish on. Hedge funds and other institutional investors usually invest large amounts of […]

Yahoo | September 15, 2020

IVERIC bio to Present at the 2020 Wedbush PacGrow Healthcare Virtual Conference

IVERIC bio announced Pravin Dugel, MD will present an overview of the Company at the Wedbush PacGrow Healthcare Virtual Conference on Aug. 12, 2020.

Yahoo | August 4, 2020

Read More 'ISEE' Stories Here

ISEE Price Returns

1-mo -22.67%
3-mo -10.17%
6-mo 21.67%
1-year -23.00%
3-year 79.07%
5-year -90.99%
YTD -22.00%
2020 -19.46%
2019 615.00%
2018 -61.54%
2017 -35.40%
2016 -93.85%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.8042 seconds.